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a b s t r a c t
Gulf War illness (GWI) is a chronic disease of unknown etiology characterized by persistent symptoms
such as cognitive impairment, unexplained fatigue, pervasive pain, headaches, and gastrointestinal
abnormalities. Current reports suggest that as many as 200,000 veterans who served in the 1990–1991
Persian Gulf War were afﬂicted. Several potential triggers of GWI have been proposed including chemical
exposure, toxins, vaccines, and unknown infectious agents. However, a deﬁnitive cause of GWI has not
been identiﬁed and a speciﬁc biological marker that can consistently delineate the disease has not been
deﬁned. Myalgic encephalomyelitis (ME) is a disease with similar and overlapping symptomology, and
subjects diagnosed with GWI typically ﬁt the diagnostic criteria for ME. For these reasons, GWI is often
considered a subgroup of ME. To explore this possibility and identify immune parameters that may help
to understand GWI pathophysiology, we measured 77 serum cytokines in subjects with GWI and com-
pared these data to that of subjects with ME as well as healthy controls. Our analysis identiﬁed a group
of cytokines that identiﬁed ME and GWI cases with sensitivities of 92.5% and 64.9%, respectively. The ﬁve
most signiﬁcant cytokines in decreasing order of importance were IL-7, IL-4, TNF-a, IL-13, and IL-17F.
When delineating GWI and ME cases from healthy controls, the observed speciﬁcity was only 33.3%, sug-
gesting that with respect to cytokine expression, GWI cases resemble control subjects to a greater extent
than ME cases across a number of parameters. These results imply that serum cytokines are representa-
tive of ME pathology to a greater extent than GWI and further suggest that the two diseases have distinct
immune proﬁles despite their overlapping symptomology.
 2014 Elsevier Ltd. All rights reserved.
1. Introduction
Gulf War illness (GWI) and myalgic encephalomyelitis (ME) are
complex diseases of unknown etiology. They are often character-
ized by a constellation of unexplained and overlapping symptoms,
which include widespread inﬂammation, fatigue, multisystemic
neuropathology, joint and muscle pain and gastrointestinal pathol-
ogy [1–3]. Although the two diseases are similar with overlapping
symptoms, GWI is a speciﬁc term given to returning military
veterans and civilian workers of the Persian Gulf War that took
place from August 2, 1990 to February 28, 1991. ME is frequently
associated with acute ﬂu-like onset as well as noninfectious
environmental triggers [4]; whereas, multiple factors including
environmental exposure, toxins, vaccines, and unknown infectious
agents have been evaluated as potential triggers for GWI [5,6].
Indeed, GWI and ME have many clinical symptoms in common
including long-term and severe fatigue that is not relieved by rest,
gastrointestinal disorders, and neurological impairments [2].
Accordingly, it has been suggested that GWI cases meet the
diagnostic criteria for ME and, therefore, represent discrete
subsets of ME. Currently, there is no pathognomonic marker for
either disease as well as no clinical diagnostic test available; for
these reasons, diagnosis is mainly based on clinical observation,
epidemiological evaluation, and medical anamnesis.
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